TRIETHYL CITRATE
Molecular Excipient
| Mwt. | LogP | HBD | HBA | PSA | RB | CSP3 |
|---|---|---|---|---|---|---|
| 276.0 | 0.2 | 1 | 7 | 99.0 | 8 | 0.75 |
- CAS
- 77930
- UNII
- 8Z96QXD6UM
- SYNONYMS
-
- ZINC ID(s)
- Availability
- Present in 31 ZINC catalogs
Known Active Genes
There has not been any activity reported at 10μM or less for this excipient (per ChEBML)
Clinical Trials
This compound has been an intervention in the following clincial trials (per clinicaltrials.gov).
| Code | Date | Title | Phase | Status |
|---|---|---|---|---|
| NCT00189670 | Randomized Phase II Trial of Dose Dense Docetaxel in N+ Breast Cancer | Phase 2 | Completed | |
| NCT02032316 | 2014-03-01 | Feasibility Study of the Uriprene Stent Following Uncomplicated Ureteroscopy | Phase 1 | Completed |
| NCT01917578 | 2008-08-01 | Study of Breast Cancer Shrinkage Modes After Neoadjuvant Chemotherapy With Whole-mount Serial Sections and Three-dimensional Pathological and MRI Reconstruction | Phase 3 | Recruiting |
| NCT00384553 | 2004-06-01 | Risk Adapted Therapy Optimization for Patients With Relapsed or Refractory Aggressive Non-Hodgkin-Lymphoma | Phase 1/Phase 2 | Recruiting |
(Browse) Purchasable Analogs in ZINC
Functions of Triethyl Citrate
| Misc - Miscellaneous |
Regulatory Status of Triethyl Citrate
| Gras - Generally recognized as safe. |
Dosages
| Route | Formulation | Per Unit Dose |
|---|---|---|
| Oral | Capsule | 17.1MG |
| Oral | Capsule, Coated Pellets | 0.59MG |
| Oral | Capsule, Delayed Action | 16.7MG |
| Oral | Capsule, Delayed Release | 1.81MG |
| Oral | Capsule, Enteric Coated Pellets | 9.16MG |
| Oral | Capsule, Extended Release | 22.23MG |
| Oral | Capsule, Hard Gelatin | 4MG |
| Oral | Capsule, Sustained Action | 7.5MG |
| Oral | Capsule, Sustained Action, Hard Gelatin | 3.3MG |
| Oral | Granule, For Oral Suspension | 6.94MG |
| Oral | Pellet | 3.8MG |
| Oral | Suspension, Sustained Action | 6.94MG |
| Oral | Tablet | 13.19MG |
| Oral | Tablet (Immed./comp. Release), Uncoated, Chewable | 2.8MG |
| Oral | Tablet, Delayed Action | 14.1MG |
| Oral | Tablet, Delayed Action, Enteric Coated | 20.18MG |
| Oral | Tablet, Delayed Release | 4MG |
| Oral | Tablet, Extended Release | 6.82MG |
| Oral | Tablet, Film Coated | 3.6MG |
| Oral | Tablet, Orally Disintegrating, Delayed Release | 18.7MG |
| Oral | Tablet, Sustained Action | 2.28MG |
| Oral | Tablet, Sustained Action, Film Coated | 0.5MG |